Home  »  Business   »  The Growth Opportunity In Verastem Inc. (NASDAQ: V...

The Growth Opportunity In Verastem Inc. (NASDAQ: VSTM)

Verastem Inc. (NASDAQ:VSTM) shares, rose in value on Thursday, 05/12/22, with the stock price up by 4.90% to the previous day’s close as strong demand from buyers drove the stock to $1.07.

Actively observing the price movement in the last trading, the stock closed the session at $1.02, falling within a range of $1.00 and $1.17. The value of beta (5-year monthly) was 0.73. Referring to stock’s 52-week performance, its high was $4.93, and the low was $1.00. On the whole, VSTM has fluctuated by -27.21% over the past month.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.

Sponsored

With the market capitalization of Verastem Inc. currently standing at about $212.04 million, investors are eagerly awaiting this quarter’s results, scheduled for Mar 16, 2022 – Mar 21, 2022. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.09, which is expected to increase to -$0.09 for fiscal year -$0.38 and then to about -$0.28 by fiscal year 2022. Data indicates that the EPS growth is expected to be 15.60% in 2022, while the next year’s EPS growth is forecast to be 26.30%.

According to the average forecast, sales growth in current quarter could jump down -90.10%, compared to the corresponding quarter of last year. Wall Street analysts also predicted that in 2022, the company’s y-o-y revenues would reach $1.6 million, representing a decrease of -98.20% from the revenues reported in the last year’s results.

Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that VSTM’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium term indicators have put the stock in the category of 100% Sell while long term indicators on average have been pointing out that it is a 100% Sell.

The stock’s technical analysis shows that the PEG ratio is about 0, with the price of VSTM currently trading nearly -27.07% and -23.13% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 35.40, while the 7-day volatility ratio is showing 13.39% which for the 30-day chart, stands at 11.65%. Furthermore, Verastem Inc. (VSTM)’s beta value is 0.88, and its average true range (ATR) is 0.15.

A comparison of Verastem Inc. (VSTM) with its peers suggests the former has fared considerably weaker in the market. VSTM showed an intraday change of 4.90% in last session, and over the past year, it shrunk by -61.79%%. In comparison, Pfizer Inc. (PFE) has moved higher at 1.90% on the day and was up 25.66% over the past 12 months. On the other hand, the price of Laboratory Corporation of America Holdings (LH) has risen 2.54% on the day. The stock, however, is off -11.55% from where it was a year ago. Additionally, there is a loss of -0.14% for GlaxoSmithKline plc (GSK) in last trading while the stock has seen an overall depriciation of 9.86%% over the past year. Other than that, the overall performance of the S&P 500 during the last trading session shows that it lost -0.13%. Meanwhile, the Dow Jones Industrial Slipped by -0.33%.

Data on historical trading for Verastem Inc. (NASDAQ:VSTM) indicates that the trading volumes over the past 3 months, they’ve averaged 2.31 million. According to company’s latest data on outstanding shares, there are 174.05 million shares outstanding.

Nearly 1.20% of Verastem Inc.’s shares belong to company insiders and institutional investors own 65.80% of the company’s shares. The stock has fallen by -47.80% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the VSTM stock heading into the next quarter.

Leave a Comment

Your email address will not be published.

Related Videos

Related Posts

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam